Risk factors and management for early and late intrahepatic recurrence of solitary hepatocellular carcinoma after curative resection

HPB

Volumn 17, Issue 5, 2015, Pages 422-427

  Cheng, Zhangjun ^a,b   Yang, Pinghua ^b   Qu, Shuping ^b   Zhou, Jiahua ^a   Yang, Jue ^b   Yang, Xinwei ^b   Xia, Yong ^b   Li, Jun ^b   Wang, Kui ^b   Yan, Zhenlin ^b   Wu, Dong ^b   Zhang, Baohua ^b   Hüser, Norbert ^c   Shen, Feng ^b  

^a SOUTHEAST UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA FETOPROTEIN; SORAFENIB;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL EVALUATION; CONSERVATIVE TREATMENT; CORRELATIONAL STUDY; FEMALE; HUMAN; INDEPENDENT VARIABLE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PARTIAL HEPATECTOMY; POSTOPERATIVE PERIOD; PREDICTOR VARIABLE; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT; SURVIVAL RATE; TUMOR ABLATION; TUMOR INVASION; ADOLESCENT; CARCINOMA, HEPATOCELLULAR; CHINA; EPIDEMIOLOGY; FOLLOW UP; INCIDENCE; LIVER NEOPLASMS; LIVER RESECTION; PROGNOSIS; TRENDS; TUMOR RECURRENCE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHINA; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 84927517100     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12367     Document Type: Article

References (29)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D,. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. de Lope CR, Tremosini S, Forner A, Reig M, Bruix J,. (2012) Management of HCC. J Hepatol 56 (Suppl 1): S75-S87.
3. Ho CM, Wu CY, Lee PH, Lai HS, Ho MC, Wu YM, et al. (2013) Analysis of the risk factors of untransplantable recurrence after primary curative resection for patients with hepatocellular carcinoma. Ann Surg Oncol 20: 2526-2533.
4. Facciuto ME, Rochon C, Pandey M, Rodriguez-Davalos M, Samaniego S, Wolf DC, et al. (2009) Surgical dilemma: liver resection or liver transplantation for hepatocellular carcinoma and cirrhosis. Intention-to-treat analysis in patients within and outwith Milan criteria. HPB 11: 398-404.
5. Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, et al. (2003) Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38: 200-207.
6. Tung-Ping Poon R, Fan ST, Wong J,. (2000) Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 232: 10-24.
7. Regimbeau JM, Abdalla EK, Vauthey JN, Lauwers GY, Durand F, Nagorney DM, et al. (2004) Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J Surg Oncol 85: 36-41.
8. Morris-Stiff G, Gomez D, de Liguori Carino N, Prasad KR,. (2009) Surgical management of hepatocellular carcinoma: is the jury still out? Surg Oncol 18: 298-321.
9. Franssen B, Jibara G, Tabrizian P, Schwartz ME, Roayaie S,. (2014) Actual 10-year survival following hepatectomy for hepatocellular carcinoma. HPB 16: 830-835.
10. Wu JC, Huang YH, Chau GY, Su CW, Lai CR, Lee PC, et al. (2009) Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma. J Hepatol 51: 890-897.
11. Cucchetti A, Piscaglia F, Caturelli E, Benvegnu L, Vivarelli M, Ercolani G, et al. (2009) Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. Ann Surg Oncol 16: 413-422.
12. Chen YJ, Yeh SH, Chen JT, Wu CC, Hsu MT, Tsai SF, et al. (2000) Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma. Gastroenterology 119: 431-440.
13. Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J,. (2000) Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 89: 500-507.
14. Bruix J, Sherman M,. (2005) Management of hepatocellular carcinoma. Hepatology 42: 1208-1236.
15. Wang K, Liu J, Yan ZL, Li J, Shi LH, Cong WM, et al. (2010) Overexpression of aspartyl-(asparaginyl)-beta-hydroxylase in hepatocellular carcinoma is associated with worse surgical outcome. Hepatology 52: 164-173.
16. Portolani N, Coniglio A, Ghidoni S, Giovanelli M, Benetti A, Tiberio GA, et al. (2006) Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg 243: 229-235.
17. Roayaie S, Blume IN, Thung SN, Guido M, Fiel MI, Hiotis S, et al. (2009) A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology 137: 850-855.
18. Poon RT, Fan ST, Lo CM, Liu CL, Wong J,. (1999) Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 229: 216-222.
19. Wang J, Li Q, Sun Y, Zheng H, Cui Y, Li H, et al. (2009) Clinicopathologic features between multicentric occurence and intrahepatic metastasis of multiple hepatocellular carcinomas related to HBV. Surg Oncol 18: 25-30.
20. Poon RT,. (2009) Differentiating early and late recurrences after resection of HCC in cirrhotic patients: implications on surveillance, prevention, and treatment strategies. Ann Surg Oncol 16: 792-794.
21. Eltawil KM, Kidd M, Giovinazzo F, Helmy AH, Salem RR,. (2010) Differentiating the impact of anatomic and non-anatomic liver resection on early recurrence in patients with Hepatocellular Carcinoma. World J Surg Oncol 8: 43.
22. Lim KC, Chow PK, Allen JC, Chia GS, Lim M, Cheow PC, et al. (2011) Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria. Ann Surg 254: 108-113.
23. Di Bisceglie AM, Sterling RK, Chung RT, Everhart JE, Dienstag JL, Bonkovsky HL, et al. (2005) Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial. J Hepatol 43: 434-441.
24. Hu KQ, Kyulo NL, Lim N, Elhazin B, Hillebrand DJ, Bock T,. (2004) Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma. Am J Gastroenterol 99: 860-865.
25. Fujiyama S, Tanaka M, Maeda S, Ashihara H, Hirata R, Tomita K,. (2002) Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma. Oncology 62 (Suppl 1): 57-63.
26. Johnson PJ,. (2001) The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma. Clin Liver Dis 5: 145-159.
27. Li T, Fan J, Qin LX, Zhou J, Sun HC, Qiu SJ, et al. (2011) Risk factors, prognosis, and management of early and late intrahepatic recurrence after resection of primary clear cell carcinoma of the liver. Ann Surg Oncol 18: 1955-1963.
28. Chan AC, Chan SC, Chok KS, Cheung TT, Chiu DW, Poon RT, et al. (2013) Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation? Liver Transpl 19: 411-419.
29. Lee SY, Konstantinidis IT, Eaton AA, Gonen M, Kingham TP, D'Angelica MI, et al. (2014) Predicting recurrence patterns after resection of hepatocellular cancer. HPB 16: 943-953.